| EO | essential oil |
| CNS | central nervous system |
| GSK-3β | glycogen synthase kinase-3β |
| sc | subcutaneous |
| PMS | premenstrual syndrome |
| GRAS | generally recognized as safe |
| i.p. | intraperitoneal |
| IC50 | median inhibitory concentration |
| NOAEL | no observed adverse effect level |
| ppm | parts per million |
| VEGF | vascular endothelial growth factor |
| GABAA | gamma-aminobutyric acid type A |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.